Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koichiro Usuku

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Journal of the Neurological Sciences|June 18, 2005
A prospective uncontrolled trial of fermented milk drink containing viable Lactobacillus casei strain Shirota in the treatment of HTLV-1 associated myelopathy/tropical spastic paraparesisToshio Matsuzaki, Mineki Saito, Koichiro Usuku, et al.
Blood|May 27, 2008
Impaired function of human T-lymphotropic virus type 1 (HTLV-1)-specific CD8+ T cells in HTLV-1-associated neurologic diseaseAmir H Sabouri, Koichiro Usuku, Daisuke Hayashi, et al.
Journal of Neurovirology|September 13, 2007
Safety and efficacy of interferon-alpha in 167 patients with human T-cell lymphotropic virus type 1-associated myelopathyKimiyoshi Arimura, Masanori Nakagawa, Shuji Izumo, et al.
The American Journal of Sports Medicine|August 9, 2013
Articular cartilage lesions increase early cartilage degeneration in knees treated by anterior cruciate ligament reconstruction: T1ρ mapping evaluation and 1-year follow-upJun Hirose, Hiroaki Nishioka, Nobukazu Okamoto, et al.
Journal of Neurosurgery. Spine|November 12, 2013
Predictive value of E-PASS and POSSUM systems for postoperative risk assessment of spinal surgeryJun Hirose, Takuya Taniwaki, Toru Fujimoto, et al.
Immunogenetics|January 13, 2006
Genetic variability in the extracellular matrix protein as a determinant of risk for developing HTLV-I-associated neurological diseaseYasuyuki Nobuhara, Koichiro Usuku, Mineki Saito, et al.
The Journal of Infectious Diseases|October 29, 2002
Molecular analysis of T cell clonotypes in muscle-infiltrating lymphocytes from patients with human T lymphotropic virus type 1 polymyositisMineki Saito, Itsuro Higuchi, Akiko Saito, et al.
Journal of the Neurological Sciences|March 21, 2006
Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals: effect of interferon alpha therapy in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)Mineki Saito, Hirohisa Nose, Koichiro Usuku, et al.
Archives of Physical Medicine and Rehabilitation|January 28, 2010
Prediction of postoperative ambulatory status 1 year after hip fracture surgeryJun Hirose, Junji Ide, Toshitake Yakushiji, et al.
Journal of the Neurological Sciences|March 31, 2004
Serum concentration and genetic polymorphism in the 5'-untraslated region of VEGF is not associated with susceptibility to HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-I infected individualsMineki Saito, Koichiro Usuku, Yasuyuki Nobuhara, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Journal of the Neurological Sciences|June 18, 2005
A prospective uncontrolled trial of fermented milk drink containing viable Lactobacillus casei strain Shirota in the treatment of HTLV-1 associated myelopathy/tropical spastic paraparesisToshio Matsuzaki, Mineki Saito, Koichiro Usuku, et al.
Blood|May 27, 2008
Impaired function of human T-lymphotropic virus type 1 (HTLV-1)-specific CD8+ T cells in HTLV-1-associated neurologic diseaseAmir H Sabouri, Koichiro Usuku, Daisuke Hayashi, et al.
Journal of Neurovirology|September 13, 2007
Safety and efficacy of interferon-alpha in 167 patients with human T-cell lymphotropic virus type 1-associated myelopathyKimiyoshi Arimura, Masanori Nakagawa, Shuji Izumo, et al.
The American Journal of Sports Medicine|August 9, 2013
Articular cartilage lesions increase early cartilage degeneration in knees treated by anterior cruciate ligament reconstruction: T1ρ mapping evaluation and 1-year follow-upJun Hirose, Hiroaki Nishioka, Nobukazu Okamoto, et al.
Journal of Neurosurgery. Spine|November 12, 2013
Predictive value of E-PASS and POSSUM systems for postoperative risk assessment of spinal surgeryJun Hirose, Takuya Taniwaki, Toru Fujimoto, et al.
Immunogenetics|January 13, 2006
Genetic variability in the extracellular matrix protein as a determinant of risk for developing HTLV-I-associated neurological diseaseYasuyuki Nobuhara, Koichiro Usuku, Mineki Saito, et al.
The Journal of Infectious Diseases|October 29, 2002
Molecular analysis of T cell clonotypes in muscle-infiltrating lymphocytes from patients with human T lymphotropic virus type 1 polymyositisMineki Saito, Itsuro Higuchi, Akiko Saito, et al.
Journal of the Neurological Sciences|March 21, 2006
Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals: effect of interferon alpha therapy in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)Mineki Saito, Hirohisa Nose, Koichiro Usuku, et al.
Archives of Physical Medicine and Rehabilitation|January 28, 2010
Prediction of postoperative ambulatory status 1 year after hip fracture surgeryJun Hirose, Junji Ide, Toshitake Yakushiji, et al.
Journal of the Neurological Sciences|March 31, 2004
Serum concentration and genetic polymorphism in the 5'-untraslated region of VEGF is not associated with susceptibility to HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-I infected individualsMineki Saito, Koichiro Usuku, Yasuyuki Nobuhara, et al.
Pageof 4